$WT
WisdomTree, Inc.

2023 Q3 Form 10-Q Financial Statement

#000119312523204008 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $90.42M $85.72M
YoY Change 24.87% 10.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $60.81M $63.22M
YoY Change 19.12% 15.28%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $300.0K $100.0K
YoY Change 200.0% 88.68%
% of Gross Profit
Operating Expenses $63.72M $67.54M
YoY Change 10.73% 9.92%
Operating Profit $26.71M $18.18M
YoY Change 79.55% 15.04%
Interest Expense $3.461M $4.021M
YoY Change -7.31% 7.71%
% of Operating Profit 12.96% 22.12%
Other Income/Expense, Net $2.601M $2.615M
YoY Change 11.92% 23.99%
Pretax Income $18.82M $57.81M
YoY Change -77.74% 441.37%
Income Tax $5.836M $3.555M
% Of Pretax Income 31.01% 6.15%
Net Earnings $12.98M $54.25M
YoY Change -84.02% 577.73%
Net Earnings / Revenue 14.36% 63.29%
Basic Earnings Per Share $0.07 $0.32
Diluted Earnings Per Share $0.07 $0.32
COMMON SHARES
Basic Shares Outstanding 150.3M 149.3M
Diluted Shares Outstanding 177.1M shares 170.7M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $168.4M $149.2M
YoY Change -34.68% -37.47%
Cash & Equivalents $89.48M $83.74M
Short-Term Investments $79.00M $65.50M
Other Short-Term Assets $1.004M $376.0K
YoY Change 202.41% -3.84%
Inventory
Prepaid Expenses $6.511M $8.161M
Receivables $35.87M $34.21M
Other Receivables $0.00 $900.0K
Total Short-Term Assets $211.8M $192.9M
YoY Change -26.83% -31.56%
LONG-TERM ASSETS
Property, Plant & Equipment $457.0K $487.0K
YoY Change -20.52% -24.02%
Goodwill $86.84M $86.84M
YoY Change 1.15% 1.15%
Intangibles $604.8M $604.4M
YoY Change 0.26% 0.4%
Long-Term Investments $37.10M $40.20M
YoY Change 39.47% 52.92%
Other Assets $447.0K $454.0K
YoY Change -41.64% -4.02%
Total Long-Term Assets $740.0M $740.9M
YoY Change 1.8% 2.24%
TOTAL ASSETS
Total Short-Term Assets $211.8M $192.9M
Total Long-Term Assets $740.0M $740.9M
Total Assets $951.8M $933.8M
YoY Change -6.35% -7.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.70M $19.00M
YoY Change 12.21% 70.63%
Accrued Expenses $28.70M $18.60M
YoY Change 3.99% -5.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $75.36M $68.28M
YoY Change -70.24% -71.74%
LONG-TERM LIABILITIES
Long-Term Debt $274.5M $274.1M
YoY Change 86.99% 86.98%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $274.5M $274.1M
YoY Change -7.95% -26.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $75.36M $68.28M
Total Long-Term Liabilities $274.5M $274.1M
Total Liabilities $349.9M $342.4M
YoY Change -36.55% -44.47%
SHAREHOLDERS EQUITY
Retained Earnings $82.01M $74.36M
YoY Change 75.05% -401.02%
Common Stock $389.0M $385.1M
YoY Change 33.8% 35.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $469.4M $458.8M
YoY Change
Total Liabilities & Shareholders Equity $951.8M $933.8M
YoY Change -6.35% -7.22%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $12.98M $54.25M
YoY Change -84.02% 577.73%
Depreciation, Depletion And Amortization $300.0K $100.0K
YoY Change 200.0% 88.68%
Cash From Operating Activities $28.40M $25.40M
YoY Change -17.92% 126.1%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $100.0K
YoY Change -166.23%
Acquisitions
YoY Change
Other Investing Activities -$16.00M $54.00M
YoY Change 540.0% -1386.33%
Cash From Investing Activities -$16.00M $53.90M
YoY Change 540.0% -1339.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.300M -115.0M
YoY Change 10.42% 2277.51%
NET CHANGE
Cash From Operating Activities 28.40M 25.40M
Cash From Investing Activities -16.00M 53.90M
Cash From Financing Activities -5.300M -115.0M
Net Change In Cash 7.100M -35.70M
YoY Change -73.99% -1843.16%
FREE CASH FLOW
Cash From Operating Activities $28.40M $25.40M
Capital Expenditures $0.00 $100.0K
Free Cash Flow $28.40M $25.30M
YoY Change -17.92% 122.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000880631
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-10932
dei Entity Registrant Name
EntityRegistrantName
WisdomTree, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3487784
dei Entity Address Address Line1
EntityAddressAddressLine1
250 West 34th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
3rd Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10119
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
801-2080
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
WT
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150324501
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83735000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132101000
CY2023Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
65492000
CY2022Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
126239000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34208000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30549000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8161000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4684000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
894000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
376000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
390000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
192866000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
293963000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
487000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544000
CY2023Q2 wt Indemnification Receivable Noncurrent
IndemnificationReceivableNoncurrent
0
CY2022Q4 wt Indemnification Receivable Noncurrent
IndemnificationReceivableNoncurrent
1353000
CY2023Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
245000
CY2022Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
259000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7626000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10536000
CY2023Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
40002000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
35721000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
849000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1449000
CY2023Q2 us-gaap Goodwill
Goodwill
86841000
CY2022Q4 us-gaap Goodwill
Goodwill
85856000
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
604407000
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
603567000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
454000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
571000
CY2023Q2 us-gaap Assets
Assets
933777000
CY2022Q4 us-gaap Assets
Assets
1033819000
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
30635000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
36521000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17800000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24121000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
849000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1125000
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
59197000
CY2023Q2 wt Deferred Consideration Current
DeferredConsiderationCurrent
0
CY2022Q4 wt Deferred Consideration Current
DeferredConsiderationCurrent
16796000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1599000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
18997000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
9075000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
68281000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
148434000
CY2023Q2 wt Carrying Value Of Convertible Notes
CarryingValueOfConvertibleNotes
274140000
CY2022Q4 wt Carrying Value Of Convertible Notes
CarryingValueOfConvertibleNotes
262019000
CY2023Q2 wt Deferred Consideration Noncurrent
DeferredConsiderationNoncurrent
0
CY2022Q4 wt Deferred Consideration Noncurrent
DeferredConsiderationNoncurrent
183494000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
339000
CY2023Q2 wt Unrecognized Tax Benefits And Interest And Penalties
UnrecognizedTaxBenefitsAndInterestAndPenalties
0
CY2022Q4 wt Unrecognized Tax Benefits And Interest And Penalties
UnrecognizedTaxBenefitsAndInterestAndPenalties
1353000
CY2023Q2 us-gaap Liabilities
Liabilities
342421000
CY2022Q4 us-gaap Liabilities
Liabilities
595639000
CY2023Q2 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
132569000
CY2022Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
132569000
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150343000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150343000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146517000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146517000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1503000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1465000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
383621000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
291847000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-693000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1420000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74356000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13719000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
458787000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
305611000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
933777000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1033819000
CY2023Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
85724000
CY2022Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
77253000
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
167768000
us-gaap Interest Expense
InterestExpense
8023000
us-gaap Operating Income Loss
OperatingIncomeLoss
34752000
us-gaap Operating Income Loss
OperatingIncomeLoss
33493000
CY2023Q2 us-gaap Interest Expense
InterestExpense
4021000
CY2022Q2 us-gaap Interest Expense
InterestExpense
3733000
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
155621000
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
26319000
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
24565000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
53717000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
49352000
CY2023Q2 wt Fund Management And Administration
FundManagementAndAdministration
17727000
CY2022Q2 wt Fund Management And Administration
FundManagementAndAdministration
16076000
wt Fund Management And Administration
FundManagementAndAdministration
34880000
wt Fund Management And Administration
FundManagementAndAdministration
31570000
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4465000
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3894000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
8472000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
7917000
CY2023Q2 us-gaap Business Development
BusinessDevelopment
3326000
CY2022Q2 us-gaap Business Development
BusinessDevelopment
3131000
us-gaap Business Development
BusinessDevelopment
6320000
us-gaap Business Development
BusinessDevelopment
5740000
CY2023Q2 wt Contractual Gold Payments
ContractualGoldPayments
1583000
CY2022Q2 wt Contractual Gold Payments
ContractualGoldPayments
4446000
wt Contractual Gold Payments
ContractualGoldPayments
6069000
wt Contractual Gold Payments
ContractualGoldPayments
8896000
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
8334000
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
4308000
us-gaap Professional Fees
ProfessionalFees
12049000
us-gaap Professional Fees
ProfessionalFees
8767000
CY2023Q2 us-gaap Communications Information Technology And Occupancy
CommunicationsInformationTechnologyAndOccupancy
1172000
CY2022Q2 us-gaap Communications Information Technology And Occupancy
CommunicationsInformationTechnologyAndOccupancy
1049000
us-gaap Communications Information Technology And Occupancy
CommunicationsInformationTechnologyAndOccupancy
2273000
us-gaap Communications Information Technology And Occupancy
CommunicationsInformationTechnologyAndOccupancy
1802000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
121000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
230000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2023Q2 wt Third Party Distribution
ThirdPartyDistribution
1881000
CY2022Q2 wt Third Party Distribution
ThirdPartyDistribution
1818000
wt Third Party Distribution
ThirdPartyDistribution
4134000
wt Third Party Distribution
ThirdPartyDistribution
4030000
CY2023Q2 us-gaap Other Expenses
OtherExpenses
2615000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
2109000
us-gaap Other Expenses
OtherExpenses
4872000
us-gaap Other Expenses
OtherExpenses
3954000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
67543000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
61449000
us-gaap Operating Expenses
OperatingExpenses
133016000
us-gaap Operating Expenses
OperatingExpenses
122128000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
18181000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15804000
us-gaap Interest Expense
InterestExpense
7465000
CY2023Q2 wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
41361000
CY2022Q2 wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
2311000
wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
61953000
wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
-14707000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
770000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2083000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1564000
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4900000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9721000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q2 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
1286000
CY2022Q2 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-4474000
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-721000
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-29181000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
57807000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10678000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75423000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16296000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3555000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2673000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4938000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14040000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
54252000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8005000
us-gaap Net Income Loss
NetIncomeLoss
70485000
us-gaap Net Income Loss
NetIncomeLoss
-2256000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144351000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143046000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144108000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142915000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170672000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158976000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165468000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142915000
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
54252000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8005000
us-gaap Net Income Loss
NetIncomeLoss
70485000
us-gaap Net Income Loss
NetIncomeLoss
-2256000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
261000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1721000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
727000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2207000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
261000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1721000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
727000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2207000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54513000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6284000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71212000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4463000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
318538000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
86801000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
45000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
156000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3970000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
261000
CY2023Q2 us-gaap Dividends
Dividends
4924000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
54252000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
458787000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
253377000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2432000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1721000
CY2022Q2 us-gaap Dividends
Dividends
4837000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8005000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
257256000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
305611000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
86801000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
45000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3540000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8506000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
727000
us-gaap Dividends
Dividends
9848000
us-gaap Net Income Loss
NetIncomeLoss
70485000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
458787000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
269424000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3394000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5368000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2207000
us-gaap Dividends
Dividends
9679000
us-gaap Net Income Loss
NetIncomeLoss
-2256000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
257256000
us-gaap Net Income Loss
NetIncomeLoss
70485000
us-gaap Net Income Loss
NetIncomeLoss
-2256000
wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
61953000
wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
-14707000
wt Advisory Fees Received In Gold
AdvisoryFeesReceivedInGold
25692000
wt Advisory Fees Received In Gold
AdvisoryFeesReceivedInGold
31511000
wt Loss Gain On Revaluation Of Deferred Consideration
LossGainOnRevaluationOfDeferredConsideration
-9721000
wt Loss Gain On Revaluation Of Deferred Consideration
LossGainOnRevaluationOfDeferredConsideration
0
us-gaap Share Based Compensation
ShareBasedCompensation
8506000
us-gaap Share Based Compensation
ShareBasedCompensation
5368000
wt Contractual Gold Payments
ContractualGoldPayments
6069000
wt Contractual Gold Payments
ContractualGoldPayments
8896000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4900000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2964000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3378000
wt Amortization Of Issuance Costs Convertible Notes
AmortizationOfIssuanceCostsConvertibleNotes
1069000
wt Amortization Of Issuance Costs Convertible Notes
AmortizationOfIssuanceCostsConvertibleNotes
1293000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
947000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-9322000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-819000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
640000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
332000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
230000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-120000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5254000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3718000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3425000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3613000
wt Increase Decrease In Gold And Other Precious Metals
IncreaseDecreaseInGoldAndOtherPreciousMetals
-18441000
wt Increase Decrease In Gold And Other Precious Metals
IncreaseDecreaseInGoldAndOtherPreciousMetals
-23743000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-347000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
241000
wt Increase Decrease In Intangibles Software Development
IncreaseDecreaseInIntangiblesSoftwareDevelopment
-946000
wt Increase Decrease In Intangibles Software Development
IncreaseDecreaseInIntangiblesSoftwareDevelopment
-724000
wt Increase Decrease In Fund Management And Administration Payable
IncreaseDecreaseInFundManagementAndAdministrationPayable
6419000
wt Increase Decrease In Fund Management And Administration Payable
IncreaseDecreaseInFundManagementAndAdministrationPayable
423000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-18941000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13537000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-2523000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-5235000
wt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
652000
wt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
348000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
9752000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
2043000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20029000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8542000
wt Purchase Of Financial Instruments Owned At Fair Value
PurchaseOfFinancialInstrumentsOwnedAtFairValue
40532000
wt Purchase Of Financial Instruments Owned At Fair Value
PurchaseOfFinancialInstrumentsOwnedAtFairValue
32488000
wt Purchase Of Investments
PurchaseOfInvestments
10000000
wt Purchase Of Investments
PurchaseOfInvestments
11863000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
985000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
205000
wt Proceeds From The Sale Of Financial Instruments Owned At Fair Value
ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue
102020000
wt Proceeds From The Sale Of Financial Instruments Owned At Fair Value
ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue
21455000
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1477000
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0
wt Proceeds From Held To Maturity Securities Maturing Or Called Prior To Maturity
ProceedsFromHeldToMaturitySecuritiesMaturingOrCalledPriorToMaturity
14000
wt Proceeds From Held To Maturity Securities Maturing Or Called Prior To Maturity
ProceedsFromHeldToMaturitySecuritiesMaturingOrCalledPriorToMaturity
31000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51936000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23070000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-184272000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0
wt Payment Of Deferred Consideration
PaymentOfDeferredConsideration
50005000
wt Payment Of Deferred Consideration
PaymentOfDeferredConsideration
0
us-gaap Payments Of Dividends
PaymentsOfDividends
9647000
us-gaap Payments Of Dividends
PaymentsOfDividends
9679000
wt Payment Of Convertible Notes Issuance Costs
PaymentOfConvertibleNotesIssuanceCosts
3548000
wt Payment Of Convertible Notes Issuance Costs
PaymentOfConvertibleNotesIssuanceCosts
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3540000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3394000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
97000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
wt Proceeds From Issuance Of Convertible Notes
ProceedsFromIssuanceOfConvertibleNotes
130000000
wt Proceeds From Issuance Of Convertible Notes
ProceedsFromIssuanceOfConvertibleNotes
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-121109000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13073000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
778000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3372000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48366000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-30973000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132101000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140709000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83735000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109736000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5900000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7724000
us-gaap Interest Paid Net
InterestPaidNet
4514000
us-gaap Interest Paid Net
InterestPaidNet
6156000
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates. </div></div></div>
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
195000
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
930000
wt Cash And Cash Equivalents Criteria Maturity Period
CashAndCashEquivalentsCriteriaMaturityPeriod
P90D
CY2022Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P12M
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P12M
wt Cash Equivalents Maturity Period
CashEquivalentsMaturityPeriod
P90D
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
17502000
CY2023Q2 wt Cash And Cash Equivalents At Carrying Value Held At One Financial Institution
CashAndCashEquivalentsAtCarryingValueHeldAtOneFinancialInstitution
83735000
CY2022Q4 wt Cash And Cash Equivalents At Carrying Value Held At One Financial Institution
CashAndCashEquivalentsAtCarryingValueHeldAtOneFinancialInstitution
132101000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6700000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
21421000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
10000000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
5000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
10000000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
11863000
CY2023Q2 wt Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome
3100000
CY2022Q2 wt Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome
12000
wt Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome
-819000
wt Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome
-151000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
30602000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11712000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
30602000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11712000
wt Disclosure Of Financial Instruments Owned At Fair Value
DisclosureOfFinancialInstrumentsOwnedAtFairValue
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5. Financial instruments owned </div></div></div></div><div style="font-weight:bold;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These instruments consist of the following: </div></div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments owned</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trading securities</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">52,616  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">    124,474  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets—seed capital (WisdomTree Digital Funds)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">12,876  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">1,765  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td> <td style="padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">  </div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">    65,492  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; padding: 0pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> $</div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 10%; padding: 0pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">126,239  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr></table> <div style="clear:both;max-height:0pt;"></div><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company</div></div> recognized net trading (losses)/gains on financial instruments owned that were still held at the reporting dates of ($222) and ($3,596) during the three months ended June 30, 2023 and 2022, respectively, and $1,309 and ($7,912) during the six months ended June 30, 2023 and 2022, respectively, which were recorded in other gains and losses, net, in the Consolidated Statements of Operations. </div>
CY2023Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
65492000
CY2022Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
126239000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
14000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
31000
CY2023Q2 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
245000
CY2022Q4 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
259000
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
19000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
20000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
226000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
239000
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
0
CY2022Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
0
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
0
CY2022Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
0
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
24000
CY2022Q4 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
27000
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
221000
CY2022Q4 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
232000
CY2023Q2 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
245000
CY2022Q4 us-gaap Held To Maturity Securities Amortized Cost Before Other Than Temporary Impairment
HeldToMaturitySecuritiesAmortizedCostBeforeOtherThanTemporaryImpairment
259000
wt Percentage Of Outstanding Convertible Note
PercentageOfOutstandingConvertibleNote
75
wt Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes At Maturity
PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity
0.50
wt Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes Before Maturity
PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity
0.75
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
550000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
418000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
487000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544000
CY2023Q2 wt Business Combination Deferred Consideration Liability
BusinessCombinationDeferredConsiderationLiability
0
CY2022Q4 wt Business Combination Deferred Consideration Liability
BusinessCombinationDeferredConsiderationLiability
200290000
CY2022 wt Business Combination Consideration Transferred Deferred Payment Interest
BusinessCombinationConsiderationTransferredDeferredPaymentInterest
0.11
CY2022Q4 wt Deferred Consideration Perpetual Growth Rate
DeferredConsiderationPerpetualGrowthRate
0.013
CY2023Q2 wt Contractual Gold Payments
ContractualGoldPayments
1583000
CY2022Q2 wt Contractual Gold Payments
ContractualGoldPayments
4446000
wt Contractual Gold Payments
ContractualGoldPayments
6069000
wt Contractual Gold Payments
ContractualGoldPayments
8896000
CY2023Q2 wt Contractual Gold Payments Gold Ounces Paid
ContractualGoldPaymentsGoldOuncesPaid
792000
CY2022Q2 wt Contractual Gold Payments Gold Ounces Paid
ContractualGoldPaymentsGoldOuncesPaid
2375000
wt Contractual Gold Payments Gold Ounces Paid
ContractualGoldPaymentsGoldOuncesPaid
3167000
wt Contractual Gold Payments Gold Ounces Paid
ContractualGoldPaymentsGoldOuncesPaid
4750000
CY2023Q2 wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
41361000
CY2022Q2 wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
2311000
wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
61953000
wt Gain Loss From Change In Deferred Consideration
GainLossFromChangeInDeferredConsideration
-14707000
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
280000000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
325000000
CY2023Q2 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
0
CY2022Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
250000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
280000000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
325250000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5860000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4034000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
274140000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
321216000
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0496
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.046
CY2018Q2 wt Fair Value Of Preferred Stock Consideration
FairValueOfPreferredStockConsideration
132750000
CY2023Q2 wt Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.0499
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
321000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
243000
us-gaap Operating Lease Cost
OperatingLeaseCost
640000
us-gaap Operating Lease Cost
OperatingLeaseCost
332000
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
65000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
251000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
121000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
527000
CY2023Q2 us-gaap Lease Cost
LeaseCost
386000
CY2022Q2 us-gaap Lease Cost
LeaseCost
494000
us-gaap Lease Cost
LeaseCost
761000
us-gaap Lease Cost
LeaseCost
859000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
326000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
251000
us-gaap Operating Lease Payments
OperatingLeasePayments
652000
us-gaap Operating Lease Payments
OperatingLeasePayments
348000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y9M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.066
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.066
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
476000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
397000
CY2023Q2 wt Lessee Operating Lease Liability Payments Due Year Two And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndThereafter
0
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
873000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
849000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
873000
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13. Contingencies </div></div></div></div> <div style="null;text-indent: 0px;;font-weight:bold;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP </div></div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In December 2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (“WT Ireland”) were served with a writ of summons to appear before the Court of Milan, Italy. In January 2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (“3OIL”) in March 2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures’ closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In February 2022, the Court of Udine ruled in the Company’s favor. Also in February 2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In March 2022, WMAI and WTUK were served with writs of summons to appear before the Court of Turin and the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers. In July 2023, the Court of Milan ruled in favor of WMAI and WTUK in respect of one of these claims. </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total damages sought by all investors related to these claims are approximately €15,200 ($16,560) at June 30, 2023. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, in July 2023, WT Ireland received a letter from counsel on behalf of additional investors seeking damages of up to approximately €</div></div></div><div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8,400 ($9,150) </div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">resulting from the closure of 3OIL. The claim is in its preliminary stages and a writ of summons has not been served. </div></div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is currently assessing these claims with its external counsel. The Company expects that losses, if any, arising from these claims will be covered under its insurance policies, less a $<div style="letter-spacing: 0px; top: 0px;;display:inline;">500</div> deductible. An accrual has not been made with respect to these matters at June 30, 2023 and December 31, 2022. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>
CY2023Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
15200000
CY2023Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
16560000
CY2023Q2 wt Loss Contingency Covered By Insurance Deductible
LossContingencyCoveredByInsuranceDeductible
500000
CY2023Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
85724000
CY2022Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
77253000
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
167768000
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
155621000
CY2023Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
85724000
CY2022Q2 us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
77253000
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
167768000
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
155621000
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
419000
us-gaap Gain Loss On Investments
GainLossOnInvestments
841000
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-313000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-1119000
CY2023Q2 wt Payment Made For Contractual Obligation
PaymentMadeForContractualObligation
45634000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
16000000
wt Stock Option Issuance Period
StockOptionIssuancePeriod
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3970000
us-gaap Share Based Compensation
ShareBasedCompensation
8506000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2432000
us-gaap Share Based Compensation
ShareBasedCompensation
5368000
CY2023Q1 wt Number Of Preferred Stock Purchase Right Issued For Outstanding Stock
NumberOfPreferredStockPurchaseRightIssuedForOutstandingStock
1000
CY2023Q1 wt Percentage Of Assets Sold
PercentageOfAssetsSold
0.50
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
54252000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8005000
us-gaap Net Income Loss
NetIncomeLoss
70485000
us-gaap Net Income Loss
NetIncomeLoss
-2256000
CY2023Q2 wt Income Distributed To Participating Securities
IncomeDistributedToParticipatingSecurities
496000
CY2022Q2 wt Income Distributed To Participating Securities
IncomeDistributedToParticipatingSecurities
548000
wt Income Distributed To Participating Securities
IncomeDistributedToParticipatingSecurities
994000
wt Income Distributed To Participating Securities
IncomeDistributedToParticipatingSecurities
1097000
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
7046000
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
358000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
7583000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
46710000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7099000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
61908000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3353000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144351000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143046000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144108000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142915000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
46710000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7099000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
61908000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3353000
CY2023Q2 wt Undistributed Income Allocable To Participating Securities
UndistributedIncomeAllocableToParticipatingSecurities
-7046000
CY2022Q2 wt Undistributed Income Allocable To Participating Securities
UndistributedIncomeAllocableToParticipatingSecurities
-358000
wt Undistributed Income Allocable To Participating Securities
UndistributedIncomeAllocableToParticipatingSecurities
-7583000
wt Undistributed Income Allocable To Participating Securities
UndistributedIncomeAllocableToParticipatingSecurities
0
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
6904000
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
357000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
7490000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
46852000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7100000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
62001000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3353000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144351000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143046000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144108000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142915000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3464000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
379000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2047000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
147815000
CY2022Q2 wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
143425000
wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
146155000
wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
142915000
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
157000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
208000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
303000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
855000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
430000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170672000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158976000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
165468000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142915000
CY2023Q2 wt Potentially Dilutive Restricted Stock Awards
PotentiallyDilutiveRestrictedStockAwards
-629000
CY2022Q2 wt Potentially Dilutive Restricted Stock Awards
PotentiallyDilutiveRestrictedStockAwards
-801000
wt Potentially Dilutive Restricted Stock Awards
PotentiallyDilutiveRestrictedStockAwards
-803000
wt Potentially Dilutive Restricted Stock Awards
PotentiallyDilutiveRestrictedStockAwards
0
CY2023Q2 wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
147815000
CY2022Q2 wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
143425000
wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
146155000
wt Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities
WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
142915000
wt Weighted Average Diluted Shares Excluding Participating Securities
WeightedAverageDilutedSharesExcludingParticipatingSecurities
15486000
wt Potentially Dilutive Common Stock Equivalents
PotentiallyDilutiveCommonStockEquivalents
356000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.061
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3555000
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4938000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2673000
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.862
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14040000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
19061000
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
17541000
CY2023Q2 wt Deferred Tax Asset Unrealized Losses
DeferredTaxAssetUnrealizedLosses
3054000
CY2022Q4 wt Deferred Tax Asset Unrealized Losses
DeferredTaxAssetUnrealizedLosses
3821000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2669000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
6030000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1583000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1609000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1289000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1526000
CY2023Q2 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1209000
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
0
CY2023Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
990000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1085000
CY2023Q2 wt Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
206000
CY2022Q4 wt Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
313000
CY2023Q2 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
184000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
173000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
127000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
255000
CY2023Q2 wt Deferred Tax Assets Outside Basis Difference
DeferredTaxAssetsOutsideBasisDifference
-122000
CY2022Q4 wt Deferred Tax Assets Outside Basis Difference
DeferredTaxAssetsOutsideBasisDifference
-122000
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
362000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
341000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30856000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
32816000
CY2023Q2 wt Deferred Tax Liabilities Fixed Assets And Prepaid Expenses
DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses
577000
CY2022Q4 wt Deferred Tax Liabilities Fixed Assets And Prepaid Expenses
DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses
278000
CY2023Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
210000
CY2022Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
205000
CY2023Q2 wt Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
206000
CY2022Q4 wt Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
313000
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
993000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
796000
CY2023Q2 wt Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
29863000
CY2022Q4 wt Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
32020000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22237000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21484000
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
7626000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
10536000
CY2023Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
19061000
wt Deferred Tax Assets Operating Loss Carryforwards Net Of Tax
DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax
1583000
CY2023Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
210000
CY2022Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
205000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
604563000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
156000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
604407000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
603617000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
603567000
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
wt-20230630_cal.xml Edgar Link unprocessable
0001193125-23-204008-index-headers.html Edgar Link pending
0001193125-23-204008-index.html Edgar Link pending
0001193125-23-204008.txt Edgar Link pending
0001193125-23-204008-xbrl.zip Edgar Link pending
d494248d10q.htm Edgar Link pending
d494248dex311.htm Edgar Link pending
d494248dex312.htm Edgar Link pending
d494248dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g494248g00a01.jpg Edgar Link pending
g494248g00a02.jpg Edgar Link pending
g494248g00a03.jpg Edgar Link pending
g494248g00a04.jpg Edgar Link pending
g494248g00a05.jpg Edgar Link pending
g494248g00a06.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d494248d10q_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wt-20230630.xsd Edgar Link pending
wt-20230630_def.xml Edgar Link unprocessable
wt-20230630_lab.xml Edgar Link unprocessable
wt-20230630_pre.xml Edgar Link unprocessable